MedTrace Logo

Graft-versus-host Disease Associated Myelosuppression

NCT02829216 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-07-12

No results posted yet for this study

Summary

The objective is to measure the frequency, functionality and phenotype of bone marrow-derived mesenchymal stromal cells in patients after allogeneic hematopoietic stem cell transplantation. Furthermore, the immune cell infiltrate of the bone marrow will be monitored at the same time. These results will be correlated with the extent of cytopenia and clinical graft-versus-host disease grading.

Conditions

  • Abnormal Hematopoiesis
  • Allogenic Disease
  • Graft vs Host Disease

Sponsors & Collaborators

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Malte von Bonin, MD · Medizinische Klinik und Poliklinik I, Universitätsklinikum, TU Dresden

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02829216 on ClinicalTrials.gov